Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
517
datasets available to search
ShareScore release 0.9.0
Dataset results
517 results for “Checkpoint inhibitors”
Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer
ClinicalTrials.gov study NCT04779489. IPD Sharing: NO. Countries: 1. Publications: 0.
NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC
ClinicalTrials.gov study NCT04880863. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma
ClinicalTrials.gov study NCT03711188. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Test the Safety and How Radium-223 Dichloride an Alpha Particle-emitting Radioactive Agent Works in Combination With Pembrolizumab an Immune Checkpoint Inhibitor in Patients With Stage IV Non
ClinicalTrials.gov study NCT03996473. IPD Sharing: NO. Countries: 4. Publications: 0.
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
ClinicalTrials.gov study NCT04305145. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer
ClinicalTrials.gov study NCT02989714. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma
ClinicalTrials.gov study NCT05308901. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Role of SNP rs2910164 in Patients Treated With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04038996. IPD Sharing: Not stated. Countries: 0. Publications: 3.
A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT03311334. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT07357636. IPD Sharing: YES. Countries: 1. Publications: 0.
Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Me
ClinicalTrials.gov study NCT02678741. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease
ClinicalTrials.gov study NCT03709771. IPD Sharing: YES. Countries: 1. Publications: 0.
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study
ClinicalTrials.gov study NCT04115410. IPD Sharing: Not stated. Countries: 0. Publications: 9.
Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04696055. IPD Sharing: NO. Countries: 8. Publications: 0.
LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors
ClinicalTrials.gov study NCT04690699. IPD Sharing: NO. Countries: 1. Publications: 0.
Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis
ClinicalTrials.gov study NCT06785974. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive
ClinicalTrials.gov study NCT05879822. IPD Sharing: YES. Countries: 9. Publications: 0.
Identification of an Immune Single Cell Transcriptomic Profile of Responder and Non-responder Hepatocellular Carcinoma Patients Treated With Immune-checkpoint Inhibitors
ClinicalTrials.gov study NCT07273708. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04925947. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Study of Bintrafusp Alfa (M7824) in Checkpoint Inhibitor Naive and Refractory Subjects With Urothelial Carcinoma
ClinicalTrials.gov study NCT04501094. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.